Sabre (SABR): Constellation’s most asymmetric bet
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Dear $AMC Apes. Your favorite stock is cheaper than last week. Maybe it is time to buy more.
$SHOE is going to get interesting:
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
EEFT · long Euronet Worldwide (EEFT) is presented as an asymmetric opportunity, citing its strong balance sheet and shareholder-friendly capital…
Carl Icahn discusses his portfolio during the coronavirus sell-off, arguing that the market’s valuation and technology-stock multiples do…
Charlie Munger chairs the Daily Journal annual meeting, reviews the decline of its newspaper business and the slow buildout of Journal…
Charlie Munger chairs the Daily Journal’s 2018 annual meeting, reviews the company’s shrinking print operation and expanding…
Charlie Munger addresses Daily Journal shareholders before taking questions at the company’s 2019 annual meeting.
Carl Icahn joins CNBC by phone after Bill Ackman closes his Herbalife short position.
Carl Icahn speaks by phone with Fox Business about Mylan, Apple, economic growth and his Herbalife stake.
Charlie Munger answers shareholder questions at the Daily Journal meeting, returning to the company’s court-software expansion and the…
Carl Icahn discusses activist investing at the 2015 DealBook Conference, arguing that long holding periods and operational changes can…
Bill Ackman presents Pershing Square’s short case against Herbalife at a Sohn Conference event.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.